• I.S. EN ISO 10993-18:2020

    Superseded A superseded Standard is one, which is fully replaced by another Standard, which is a new edition of the same Standard.

    Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020)

    Available format(s):  Hardcopy, PDF

    Superseded date:  06-02-2021

    Language(s):  English

    Published date:  14-06-2020

    Publisher:  National Standards Authority of Ireland

    For Harmonized Standards, check the EU site to confirm that the Standard is cited in the Official Journal.
    Only cited Standards give presumption of conformance to New Approach Directives/Regulations.

    Dates of withdrawal of national standards are available from NSAI.

    Add To Cart

    Table of Contents - (Show below) - (Hide below)

    Foreword
    Introduction
    1 Scope
    2 Normative references
    3 Terms and definitions
    4 Symbols and abbreviated terms
    5 Characterization procedure
    6 Chemical characterization parameters and methods
    7 Reporting of the chemical characterization data
    Annex A (informative) General principles of chemical characterization
    Annex B (informative) Information sources for chemical characterization
    Annex C (informative) Principles for establishing biological equivalence
    Annex D (informative) Principles of sample extraction
    Annex E (informative) Calculation and application of the analytical evaluation threshold (AET)
    Annex F (informative) Qualification of analytical methods used for extractables/leachables
    Annex G (informative) Reporting details for analytical methods and chemical data
    Bibliography

    Abstract - (Show below) - (Hide below)

    This document specifies a framework for the identification, and if necessary, quantification of constituents of a medical device, allowing the identification of biological hazards and the estimation and control of biological risks from material constituents, using a generally stepwise approach to the chemical characterization which can include one or more of the following: — the identification of its materials of construction (medical device configuration); — the characterization of the materials of construction via the identification and quantification of their chemical constituents (material composition); — the characterization of the medical device for chemical substances that were introduced during manufacturing (e.g. mould release agents, process contaminants, sterilization residues); — the estimation (using laboratory extraction conditions) of the potential of the medical device, or its materials of construction, to release chemical substances under clinical use conditions (extractables); — the measurement of chemical substances released from a medical device under its clinical conditions of use (leachables).

    General Product Information - (Show below) - (Hide below)

    Committee TC 194
    Document Type Standard
    Product Note The date of any NSAI previous adoption may not matchthe date of its original CEN/CENELEC document.
    Publisher National Standards Authority of Ireland
    Status Superseded
    Superseded By
    Supersedes
    • Access your standards online with a subscription

      Features

      • Simple online access to standards, technical information and regulations
      • Critical updates of standards and customisable alerts and notifications
      • Multi - user online standards collection: secure, flexibile and cost effective